Kevin W. Ward
- Infectious Diseases top 5%
- Molecular Medicine top 1%
- Clinical Biochemistry top 1%
- Pharmacology top 5%
- Epidemiology
- Co-authors
- David A. BrucknerJanet HindlerGuiqing WangRomney M. HumphriesShangxin YangJanet A. HindlerPeera HemarajataShelley A. Miller
- Topics
- Antibiotic Resistance in Bacteria (12 papers)Bacterial Identification and Susceptibility Testing (9 papers)Antimicrobial Resistance in Staphylococcus (5 papers)
- Journals
- Clinical Infectious DiseasesJournal of Clinical MicrobiologyAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Kevin W. Ward
25 papers receiving 853 citations
Peers
Comparison fields: 5 of 78
- Infectious Diseases 424
- Molecular Medicine 380
- Clinical Biochemistry 315
- Pharmacology 258
- Epidemiology 195
Countries citing papers authored by Kevin W. Ward
This map shows the geographic impact of Kevin W. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin W. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin W. Ward more than expected).
Fields of papers citing papers by Kevin W. Ward
This network shows the impact of papers produced by Kevin W. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin W. Ward. The network helps show where Kevin W. Ward may publish in the future.
Co-authorship network of co-authors of Kevin W. Ward
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin W. Ward. A scholar is included among the top collaborators of Kevin W. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin W. Ward. Kevin W. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 16 | |
| 4 | 9 | |
| 5 | 4 | |
| 6 | 14 | |
| 7 | 12 | |
| 8 | 1 | |
| 9 | 40 | |
| 10 | 3 | |
| 11 | 59 | |
| 12 | 5 | |
| 13 | 52 | |
| 14 | 299 | |
| 15 | 8 | |
| 16 | 9 | |
| 17 | 43 | |
| 18 | 0 | |
| 19 | 25 | |
| 20 | Cefotaxime clinical trial results in septicaemic patients in Ireland and the U.K. | 12 |
About Kevin W. Ward
Kevin W. Ward is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry, having authored 26 papers that have together received 885 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). The work is most often cited by research in Molecular Medicine (380 citations), Applied Microbiology and Biotechnology (108 citations) and Clinical Biochemistry (315 citations). Kevin W. Ward has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include David A. Bruckner, Janet Hindler, Guiqing Wang, Romney M. Humphries, Shangxin Yang, Janet A. Hindler, Peera Hemarajata, Shelley A. Miller, Aric L. Gregson and Michael A. Lewinski. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.